Dr. David J. Schanzlin, MD

Dr. Schanzlin practices at UCSD Ambulatory Surgery Center, LLC in La Jolla, California.

Dr. Schanzlin's NPI, 1528016417, was assigned on May 4, 2006. Dr. Schanzlin graduated from Pritzker School of Medicine in 1975. Dr. Schanzlin holds California license G39468.

Dr. Schanzlin's primary practice is UCSD Ambulatory Surgery Center, LLC, at 4120 La Jolla Village Dr, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 657-0055.

Dr. Schanzlin's primary practice is UCSD Ambulatory Surgery Center, LLC in La Jolla, California. Dmand AI also links Dr. Schanzlin to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schanzlin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Schanzlin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Schanzlin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Schanzlin's licenses on file in 3 states: California, Missouri and Illinois.

Dmand AI lists cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, hereditary corneal conditions and secondary membranaous cataract surgery among the conditions Dr. Schanzlin treats.

CMS data shows 139 Medicare services from Dr. Schanzlin across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $9,741 for them. Every service was in an office.

CMS counts 78 Medicare patients who saw Dr. Schanzlin in 2024. The largest group is 75 to 84, with 42 patients. 74% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schanzlin's median patient age at 63, with 49% women.

In 2024, Dr. Schanzlin wrote 102 Medicare Part D claims for 36 patients. 40% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $2,716 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schanzlin for performance year 2024, reported as part of a group. Dr. Schanzlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Schanzlin, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Schanzlin, published from 2011 to 2024. The most frequent topics are Cornea, Visual Acuity and Myopia. Dr. Schanzlin has published most often in Ophthalmology. Dr. Schanzlin's most frequent co-authors are Steven Maytham Verity, MD, Jeffrey B. Robin, MD and Kenneth Robert Diddie, MD.

Dmand AI links Dr. Schanzlin to 4 clinical trials. Conditions studied include Presbyopia, Refractive Errors and Corneal Diseases. University of California, San Diego sponsors the most, 2.

CMS Open Payments shows 310 general payments to Dr. Schanzlin from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Oasis Medical, Inc. paid the most, $123,000.

Dmand AI lists 2 awards for Dr. Schanzlin.

Dr. Schanzlin graduated from Pritzker School of Medicine in 1975. Dr. Schanzlin is a member of AAO.

Dr. Schanzlin is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.